The aim of this paper is to provide guidelines for the pathologist on the definition, nomenclature, and classification of hepatic cirrhosis and related conditions. The many systems of classification in current use (Table 1) hinder rather than help comparisons of published data and the evaluation of relationships between cirrhosis and liver cancer. Different words have been used to describe essentially similar features, and a single word is sometimes applied to a variety of forms. The terminology of many classifications is based on a mixture of pathogenesis, morphology, and aetiology (for example, 'post-necrotic', 'portal', and 'biliary' cirrhosis). There is, therefore, a need for a logical and readily reproducible system.
In the preparation of these guidelines, comments and criticisms from a number of other pathologists and hepatologists throughout the world have been taken into account. An attempt has been made to study a wide variety of material from different geographical areas.
Cirrhosis

DEFINITION
It is generally agreed that cirrhosis is best defined in 'This is an abbreviated version of the original published in the Bulletin of the World Health Organization (4, (521) (522) (523) (524) (525) (526) (527) (528) (529) (530) (531) (532) (533) (534) (535) (536) (537) (538) (539) (540) 1977) .
Received for publication 7 November 1977 morphological terms but, in spite of many attempts, no single definition exists that does not require further elaboration or qualification. The essential features are considered to be parenchymal necrosis, regeneration, and diffuse fibrosis, resulting in disorganisation of the lobular architecture throughout the whole of the liver. There are many who consider that the altered vascular relationships are an equally or even more important feature. All would agree, however, that cirrhosis is a chronic, progressive condition that results in liver cell dysfunction and portal hypertension. Instances of regression from established cirrhosis to normal liver architecture are rare and open to doubt.
In this article cirrhosis is defined as a diffuseprocess characterized by fibrosis and the conversion ofnormal liver architecture into structurally abnormal nodules.
The process is diffuse in the sense that it involves the whole organ. Focal lesions, eg, focal nodular hyperplasia, do not constitute cirrhosis. Diffuse nodularity without fibrosis, eg, the nodular hyperplasia associated with Felty's syndrome or induced by drugs and chemicals, is not cirrhosis, nor is diffuse fibrosis without nodularity, eg, hepatoportal sclerosis. There are conditions in which both generalised fibrosis and nodularity are present, eg, congenital hepatic fibrosis, but which are not considered to constitute cirrhosis because the lobular architecture is largely maintained.
It is generally assumed that fibrosis is the result of 395 P. P. Anthony, K. G. Ishak, N. C. Nayak, H. E. Poulsen, P. J. Scheuer, aud L. H. Sohin (Figs. 2, 4 , 5, 7). Many nodules are over 3 mm in diameter but the size varies considerably and some nodules measure several centimetres. They may contain portal structures and efferent veins, but these are abnormally related to each other. Two subcategories can be recognised. In one, the macronodules are divided by slender, sometimes incomplete septa, which link mainly portal tracts. The fine, reticulate pattern of fibrosis makes nodularity unapparent to naked-eye examination and renders histological diagnosis difficult. This seems to be a common pattern in the tropics and subtropics ('incomplete septal' or 'posthepatitic' pattern) . In the other subcategory, the liver is more coarsely scarred, with obvious macronodules surrounded by broad fibrous septa. These may contain several portal tracts. This pattern has been assumed to result from necrosis of large areas of parenchyma ('postcollapse' or 'postnecrotic' pattern).
(c) Mixedpattern. When micro and macro nodules are present in approximately equal proportions the term 'mixed' may be applied.
The size of the liver, as seen post mortem, is of some additional interest. Micronodular cirrhotic livers are often normal in size or enlarged, particularly when fatty. Macronodular cirrhotic livers may be normal but are often reduced in size, especially when coarsely scarred.
Aetiology
The first of the three categories listed below includes established associations between aetiological factors and cirrhosis, but the precise nature of the associa- tions and of the pathogenetic mechanisms involved is often far from clear. Aetiological diagnosis is usually reached by a combination of epidemiological, clinical, biochemical, immunological, and histological investigations.
In the second category the association between an aetiological agent and cirrhosis is debatable or controversial. group.bmj.com on November 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from P. P. Anthony, K. G. Ishak, N. C. Nayak, H. E. Poulsen, P. J. Scheuer, and L. H. Sobin ing portal fibrosis and septum formation with iron in liver cells, phagocytes, and bile-duct epithelium. Inflammation is usually slight, and, apart from the siderosis, the parenchyma is little altered.
(d) Wilson's disease (Fig. 12a) . The morphological pattern of cirrhosis varies, but large nodules are common. Fatty change, nuclear vacuolation, and Mallory's hyalin may be prominent. The cirrhosis may show considerable activity, with piecemeal necrosis and inflammatory infiltration. Increased amounts of copper can sometimes be demonstrated, but copper is also found in some other conditions, notably primary biliary cirrhosis and other examples of chronic cholestasis.
(e) Alpha-l-antitrypsin deficiency (Fig. 12b) . In homozygous (Pi ZZ) subjects the liver may be normal or abnormal, and a wide variety of disease patterns is found, ranging from hepatitis to cirrhosis. The latter sometimes resembles the cirrhosis which follows prolonged biliary obstruction. Intracytoplasmic globules of faintly eosinophilic material, which are positive with the PAS stain after diastase digestion, are characteristic. Similar globules have rarely been found in the absence of liver disease or emphysema.
(f) Primary biiary cirrhosis (Fig. 13 ). Small and medium-sized bile ducts are hyperplastic or necrotic and are surrounded and infiltrated by plasma cells, lymphocytes, eosinophil leucocytes, and epithelioid cells. Ill-defined or well-organised granulomas form, usually near the damaged bile ducts. The lesions are focal and may be missed unless several sections are examined. Later, the damaged ducts are replaced by loose lymphoid aggregates, there is increasingfibrosis, and cholestasis is present at the periphery of the lobules. Mallory's hyalin sometimes is prominent and stains for copper are often positive. Lobular architecture remains intact for long periods. When cirrhosis is established paucity of bile ducts may suggest that it is primary rather than secondary to longstanding obstruction.
(g) Secondary biiary cirrhosis (Fig. 14) . Portal fibrosis and septum formation predominate, and parenchymal alterations are often slight. There may be morphological cholestasis due to persisting obstruction to bile ducts, but this is not invariable or necessary for diagnosis. Lobular architecture survives for long periods, and groups of adjacent nodules form complex parenchymal islands resembling the pieces of a jig-saw puzzle.
(h) Venous outflow obstruction (Fig. 15) (j) Intestinal bypass operations for obesity. Fatty change is common, and hepatic fibrosis may develop. Cirrhosis is rare, and the appearances may be identical with those seen in the alcoholic.
(k) Indian childhood cirrhosis. The cirrhosis is typically micronodular in pattern, and there is fibrosis around individual cells or small groups. Mallory's hyalin is prominent, widespread, and not recognizably centrilobular as it is in alcoholic hepatitis. Fatty change is usually absent. Activity This is measured by the degree of liver cell destruction and inflammatory infiltration, and its assessment is an important part of diagnosis. Piecemeal necrosis at the margins of septa is usually considered the most relevant form of necrosis in this respect, but other forms (eg, acidophilic bodies, focal necrosis) should also be taken into account. In cirrhosis due to alcoholism, for example, activity in the early stages may be largely in the form of alcoholic hepatitis, while later, perhaps after improved drinking habits, piecemeal necrosis and infiltration by lymphocytes and plasma cells may become more important. It is customary to grade activity in biopsy specimens as slight, moderate, or severe, but it should be remembered that activity may have been modified by treatment and that the sample of liver tissue may not be representative. Complications and secondary phenomena (a) Ischaemic necrosis. This may be focal, with coagulative necrosis of small groups of cells, or involve whole nodules or centres of nodules. It with hepatocellular (or liver-cell) carcinoma but not with cholangiocarcinoma (intrahepatic bile duct carcinoma). The increased risk of malignancy may depend on the aetiology and the duration of the cirrhotic process.
Liver-cell hyperplasia in cirrhosis sometimes produces distinct, tumour-like nodules made up of double liver-cell plates with increased cytoplasmic basophilia. The term 'adenomatoid hyperplasia' has been applied to such appearances. There is no evidence that it is associated with an increased risk of malignancy.
Malignancy is often associated with, and may be preceded by, liver cell dysplasia (Fig. 16) . The term refers to cellular enlargement, which affects both nucleus and cytoplasm, together with nuclear pleomorphism, multinucleation, and occasional mitoses. These changes may involve groups of liver cells or, less commonly, whole cirrhotic nodules. Liver-cell dysplasia is most frequently seen in macronodular cirrhosis, at an earlier age than hepatocellular carcinoma, and more commonly in males. It is also more frequently seen in areas where hepatocellular carcinoma is common, and its presence has been associated with the hepatitis B antigen. ss---ts--s -w--sw--X -w. 'chronic lobular hepatitis' has been used by some authors. Chronic persistent hepatitis carries a good prognosis, and only a minority of patients progress to chronic active hepatitis.
(b) Chronic active hepatitis (Figs 18, 19) . Inflammation affects portal tracts but is also seen in the lobules. The infiltrate is typically rich in lymphocytes and plasma cells. There is more fibrosis than in chronic persistent hepatitis, the lobules are involved, and lobular architecture is often altered. Piecemeal, bridging, and multilobular necrosis may be seen. Chronic active hepatitis has a worse overall prognosis than chronic persistent hepatitis and tends to progress to cirrhosis, but the milder forms may regress to chronic persistent hepatitis or fibrosis, especially after treatment. Chronic hepatitis and liver cancer rarely co-exist.
The lack of specificity of the picture of chronic persistent hepatitis has been referred to above, and similar appearances can be found in so-called non-specific hepatitis due to a large variety of causes. Chronic active hepatitis may follow acute viral hepatitis, often identifiable as type B. It may be due to drugs (for example, oxyphenisatin, alpha methyldopa, isoniazid) or associated with chronic inflammatory bowel disease. In a minority of patients with Wilson's disease and in some alcoholics, the histological picture is predominantly that of chronic active hepatitis. In patients with no known aetiological factors but with high serum levels of abnormal antibodies (for example, against smooth muscle) and multisystem disease, a primary disturbance of immunity has been postulated ('lupoid hepatitis').
DIAGNOSIS
Certain difficulties should be borne in mind when needle biopsy specimens are examined:
1 The histological distinction between acute and chronic hepatitis is often difficult in the first months after an acute attack and tends to become easier with time.
2 The lesions of chronic persistent and chronic active hepatitis may be unevenly distributed throughout the liver, and an incorrect diagnosis may be made if the sample is small.
3 Treatment, for example with corticosteroids, can suppress manifestations of activity and lead to a falsely optimistic impression.
4 It may be difficult to assess whether cirrhosis is present or absent on the basis of a needle biopsy specimen in chronic active hepatitis. 
